406 related articles for article (PubMed ID: 10215560)
21. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
22. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
Loew A; Jacob D; Neuhaus P; Riess H
Transplantation; 2005 May; 79(10):1422-7. PubMed ID: 15912114
[TBL] [Abstract][Full Text] [Related]
23. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
24. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
[TBL] [Abstract][Full Text] [Related]
25. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
[TBL] [Abstract][Full Text] [Related]
26. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
27. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors.
Folsom AR; Cushman M; Tsai MY; Aleksic N; Heckbert SR; Boland LL; Tsai AW; Yanez ND; Rosamond WD
Blood; 2002 Apr; 99(8):2720-5. PubMed ID: 11929758
[TBL] [Abstract][Full Text] [Related]
29. Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
MacLean RM; Feeney GP; Bowley SJ; Bowen DJ; Worwood M; Collins PW
Br J Haematol; 1999 Oct; 107(1):210-2. PubMed ID: 10520044
[TBL] [Abstract][Full Text] [Related]
30. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.
Juul K; Tybjaerg-Hansen A; Schnohr P; Nordestgaard BG
Ann Intern Med; 2004 Mar; 140(5):330-7. PubMed ID: 14996674
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for thromboembolism.
Jay SJ
Ann Intern Med; 1999 Nov; 131(10):790; author reply 790-1. PubMed ID: 10577306
[No Abstract] [Full Text] [Related]
32. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
[TBL] [Abstract][Full Text] [Related]
33. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
34. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
35. Comparison of three activated protein C resistance tests in the risk assessment of venous thrombosis in non-carriers of the factor V Leiden mutation.
Guerrero F; Arnaud C; Nguyen F; Boneu B; Sié P
Thromb Haemost; 2006 Apr; 95(4):728-34. PubMed ID: 16601846
[TBL] [Abstract][Full Text] [Related]
36. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
[TBL] [Abstract][Full Text] [Related]
37. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
[TBL] [Abstract][Full Text] [Related]
38. The effect of factor V Leiden carriage on maternal and fetal health.
Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
[TBL] [Abstract][Full Text] [Related]
39. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
40. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
